Icon Group plants flag in UK

Australian oncology specialist, Icon Group takes first steps in UK market with takeover of Pharmaxo Group  Icon is aiming to help close gaps in access to cancer medications in the UK through its acquisition of the Wiltshire-based compounder.   Announcing the deal, Mark Middleton, Icon’s chief executive, said the acquisition reflected the company’s “ongoing commitment